Covid-19 Vaccine Update: Pfizer-Biotech Vaccine Rollout In The US Begins Today
Three million US residents are expected to be vaccinated during this first phase. Read on to know more.
With US tolls for coronavirus crossing 16 million, the vaccine Pfizer certainly came in as a ray of hope for the US residents. According to authorities, the first phase of the much-awaited Pfizer-BioNTech vaccine rollout started from today onwards. The US Army general officer who is currently acting as the chief operating officer of government’s operation Warp Speed gave a detailed description of the rollout.
The Pfizer-BioNTech coronavirus shots left the Pfizer factory in Kalamazoo, Michigan on Sunday. The vaccine was transported stored in boxes containing dry ice that are capable of staying at -70 degrees Celsius (-94 degrees Fahrenheit). This frigid temperature is required to preserve the drug.
The army general said that he is absolutely confident that the vaccine will be distributed safely. He added that 145 sites across the States will receive the vaccine on Monday, 14 December. He further informed that 125 sites and 66 sites will be distributed on 15 December and 16 December respectively.
Pfizer has tie-ups with companies like FedEx and UPS which have the logistical abilities to supply medicines at low temperatures. Federal health authorities have recommended that health care workers and nursing home residents be at the front of the line, but the final decisions have been left to states. In the first phase, it is expected that over 3 million people will be vaccinated with Pfizer-BioNtech vaccine. FDA authorized emergency use of COVID-19 vaccine on Friday.
The vaccine is found 95% effective in preventing COVID-19. The head of U.S food and drug administration on Saturday said the efforts to distribute the nation’s first vaccine are well and truly underway. The FDA commissioner also gave a green signal to the vaccine and also said that they have applied their high standards in reviewing the vaccine with a hope that the US resident would develop a trust that this vaccine meets the rigorous standards of FDA’s policies to ensure complete medical safety in the nation. The United States is currently one of the worst affected nations due to the COVID-19 pandemic.